Literature DB >> 19756642

[Intensive intracorneal keloid formation in a case of Peters plus syndrome and in Peters anomaly with maximum manifestation].

P Eberwein1, T Reinhard, H Agostini, C M Poloschek, R Guthoff, C Auw-Haedrich.   

Abstract

We present two cases of Peters anomaly (Peters plus syndrome and a maximum manifestation variant) with abnormally thickened cornea and corneal staphyloma. Both patients presented to our hospital shortly after birth and were treated with perforating keratoplasty and lensectomy. Histological analysis showed marked thickening of the corneal stroma due to abnormal stromal connective tissue deposition. Additionally, both eyes showed the characteristic changes of Peters anomaly with corneal opacity, adherence of the iris stroma and anterior lens surface to the posterior corneal surface, absence of the corneal endothelium, Descemet and Bowmans layers. Peters anomaly with abnormally thick intracorneal fibrosis with or without congenital corneal staphyloma is a very rare manifestation.

Entities:  

Mesh:

Year:  2010        PMID: 19756642     DOI: 10.1007/s00347-009-2014-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

Review 1.  Peters' anomaly. A synopsis of surgical management and visual outcome.

Authors:  L L Yang; S R Lambert
Journal:  Ophthalmol Clin North Am       Date:  2001-09

2.  Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous.

Authors:  A Matsubara; H Ozeki; N Matsunaga; M Nozaki; M Ashikari; S Shirai; Y Ogura
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

3.  Corneoscleral transplantation in congenital corneal staphyloma and Peters' anomaly.

Authors:  Marijean M Miller; Selim Butrus; Ahmed Hidayat; Lisa L Wei; Manuel Pontigo
Journal:  Ophthalmic Genet       Date:  2003-03       Impact factor: 1.803

4.  A mutation in the RIEG1 gene associated with Peters' anomaly.

Authors:  W Doward; R Perveen; I C Lloyd; A E Ridgway; L Wilson; G C Black
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

5.  Outcome of penetrating keratoplasty for Peters anomaly.

Authors:  Kavita V Rao; Merle Fernandes; Nibaran Gangopadhyay; Geeta K Vemuganti; Sannapaneni Krishnaiah; Virender S Sangwan
Journal:  Cornea       Date:  2008-08       Impact factor: 2.651

Review 6.  Corneal keloid.

Authors:  M Vanathi; Anita Panda; Sanjay Kai; Seema Sen
Journal:  Ocul Surf       Date:  2008-10       Impact factor: 5.033

7.  Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase.

Authors:  Saskia A J Lesnik Oberstein; Marjolein Kriek; Stefan J White; Margot E Kalf; Karoly Szuhai; Johan T den Dunnen; Martijn H Breuning; Raoul C M Hennekam
Journal:  Am J Hum Genet       Date:  2006-07-19       Impact factor: 11.025

8.  Peters' anomaly associated with protruding corneal pseudo staphyloma.

Authors:  G W Zaidman; K Juechter
Journal:  Cornea       Date:  1998-03       Impact factor: 2.651

9.  Unilateral congenital corneal staphyloma with retinal neovascularization. A case report.

Authors:  K U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly.

Authors:  I M Hanson; J M Fletcher; T Jordan; A Brown; D Taylor; R J Adams; H H Punnett; V van Heyningen
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

View more
  2 in total

1.  Basic Components of Connective Tissues and Extracellular Matrix: Fibronectin, Fibrinogen, Laminin, Elastin, Fibrillins, Fibulins, Matrilins, Tenascins and Thrombospondins.

Authors:  Jaroslava Halper
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Mutations of the CYP1B1 gene in congenital anterior staphylomas.

Authors:  Ramzi Al Judaibi; Khaled K Abu-Amero; Jose Morales; Sami Al Shahwan; Deepak P Edward
Journal:  Clin Ophthalmol       Date:  2014-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.